A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

GEMO Study Collaborators, EMBRACE Collaborators, Andrea Gehrig, Vassilios Georgoulias, Graham G Giles, A K Godwin, Mark S. Goldberg, David Goldgar, Anna González-Neira, Mark H Greene, Pascal Guénel, Lothar Haeberle

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Abstract

Abstract: Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P <10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Original languageEnglish
Article number1078
Number of pages22
JournalNature Communications
Volume12
Issue number1
Early online date17 Feb 2021
DOIs
Publication statusPublished - 14 May 2021

Fingerprint

Dive into the research topics of 'A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers'. Together they form a unique fingerprint.

Cite this